Answer
Breastfeeding should be discontinued during treatment with Velcade (bortezomib) because serious adverse reactions could occur in breastfed infants, although whether bortezomib is excreted in human milk is unknown.
Sources for this answer
- Velcade 3.5mg powder for solution for injection (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 37Document updated
Sources checked